FDA approves shock wave device for treatment of diabetic foot ulcers

January 1, 2018January 1, 2018 Wound Care Advisor

On December 28, 2017, the FDA gave approval for the Dermapace System, a shock wave device intended to be used in the treatment of chronic, full-thickness diabetic foot ulcers. The device uses pulses of energy, similar to sound waves, to mechanically stimulate the wound. Read more.

Related posts

• 

  Electrically charged bandages help to heal burn wounds, combat antibiotic resistance

  Ohio State University Wexner Medical Center researchers have created...

• 

  Diabetic foot ulcers heal faster with probiotic supplementation

  Findings from a randomized controlled trial revealed that patients with...

• 

  Topical gel containing blood pressure drugs shown effective in healing chronic wounds

  An international research team led by Johns Hopkins University...

• 

  New smartphone app measures wound depth

  Swift Medical, a wound care company based in Toronto, has...

• 

  UVA student invents a new type of five-layered wound technology

  Ashwinraj Karthikeyan, a student in UVA’s School of Engineering and...

• 

  Bacterial biofilms, begone

  By some estimates, bacterial strains resistant to antibiotics —...